Status:
COMPLETED
Survival Outcomes by Tumor-Node Stage and Recurrence Patterns in Colon Cancer After Radical Surgery
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Colon Cancer
Colon Adenocarcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Colon cancer is one of the most common cancers worldwide, and even after curative (radical) surgery, some patients develop recurrence or distant metastasis. Understanding how tumor stage and lymph nod...
Detailed Description
Colon cancer remains a major cause of cancer-related morbidity and mortality worldwide. Even after curative resection, recurrence occurs in a significant proportion of patients, and survival outcomes ...
Eligibility Criteria
Inclusion
- Patients with histologically confirmed colon adenocarcinoma
- Stage I-III disease at diagnosis
- Underwent curative (radical) resection at Chang Gung Memorial Hospital between 2006 and 2018
- Availability of complete clinical, pathological, and follow-up data
Exclusion
- Stage IV colon cancer at initial diagnosis
- Non-adenocarcinoma histology (e.g., undifferentiated carcinoma, squamous cell carcinoma, lymphoma, sarcoma)
- History of other malignancies or synchronous multiple cancers
- Patients who underwent only palliative surgery or local excision
- Incomplete medical records or missing follow-up information
Key Trial Info
Start Date :
April 9 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
7259 Patients enrolled
Trial Details
Trial ID
NCT07167147
Start Date
April 9 2025
End Date
August 1 2025
Last Update
September 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital, Linkou
Taoyuan District, Taoyuan, Taiwan, 33305